ClinicalTrials.gov
public full text
Public Domain
Noradrenalin vs Terlipressin in Hepatorenal Syndrome
The purpose of this study is to determine whether noradrenalin is as effective and safe as terlipressin in the treatment of hepatorenal syndrome
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- U.S. Experience with Terlipressin in Hepatorenal Syndrome: Response, Mortality, and Transplant Outcomes - Results from the HRS Harmony Consortium.#218936
- A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1#806894
- MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)#160219
- Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1#893273
- Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI)#462543
Record · ID 1008908
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive